University College London Hospitals NHS Foundation Trust — London, London

Public research footprint of University College London Hospitals NHS Foundation Trust, compiled from the ClinicalTrials.gov public registry.

274

Registered studies

106

Active

Recruiting now

108

Completed

Stopped or withdrawn

Most-studied conditions

Myotonic Dystrophy Type 1 (DM1) · Ovarian Cancer · Non-Small Cell Lung Cancer · Early Parkinson Disease (Early PD)

Recently updated registry entries

NCT05488314 — A Study of Amivantamab and Capmatinib Combination Therapy in Unresectable Metastatic… (Active Not Recruiting)
NCT07499232 — A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely… (Recruiting)
NCT05901649 — A Study for the Participants With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)… (Completed)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University College London Hospitals NHS Foundation Trust?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.